<!DOCTYPE HTML>
<!--
	Landed by HTML5 UP
	html5up.net | @ajlkn
	Free for personal and commercial use under the CCA 3.0 license (html5up.net/license)
-->
<html>
	<head>
		<title>Nilay Vora | Portfolio</title>
		<meta charset="utf-8" />
		<meta name="viewport" content="width=device-width, initial-scale=1, user-scalable=no" />
		<link rel="stylesheet" href="assets/css/main.css" />
		<link rel="icon" href="./images/Identity.png" type="image/png"/>
		<noscript><link rel="stylesheet" href="assets/css/noscript.css" /></noscript>
	</head>
	<body class="is-preload" style= background-color:white;>
		<div id="page-wrapper">

			<!-- Header -->
				<header id="header">
					<img src="images/Logo.png" alt="logo" />
					<h1 id="logo"><a href="index.html">Nilay Vora</a></h1>
					<nav id="nav">
						<ul>
							<li><a href="index.html">Home</a></li>
							<li><a href="About.html">About Me</a></li>
							<li>
								<a href="#">Projects</a>
								<ul>
									<li><a href="#">Research</a>
										<ul>
											<li><a href="CTCC.html">ML Label-Free Flow Cytometry</a></li>
											<li><a href="Denoising2PImages.html">DL Denoising Two-Photon Microscopy Images</a></li>	
										</ul>
									</li>
									<li><a href="#">Outreach</a>
										<ul>
											<li><a href="TOJC.html">Tufts Optics Journal Club</a></li>
										</ul>
									</li>
								</ul>
							</li>
							<li><a href="Experience.html">Experience</a></li>
							<li><a href="mailto:nilay.vora@tufts.edu" class="button primary">Contact Me</a></li>
						</ul>
					</nav>
				</header>
            
            <!-- Main -->
				<div id="main" class="wrapper style1">
					<div class="container">
						<header class="major">
							<h2 style="color:black">ML-Enabled, Label-free Detection of Rare Circulating Tumor Cell Clusters (CTCCs) in Whole Blood</h2>
						</header>
						<div class="row gtr-150">
							<div class="col-4 col-12-medium">

								<!-- Sidebar -->
									<section id="sidebar">
										<section>
											<h3 style="color:black">What is Cancer?</h3>
											<figure>
												<a href="https://doi.org/10.1016/j.jsamd.2019.01.006" class="image fit">
													<img src="images/Rostami et al.png" alt="Schematic of Metastasis and CTCC microenvironment." />
												</a>
												<figcaption style="color:black">
													Figure 1: (a) Tumor cells are shed from a primary tumor into the bloodstream as single CTCs or rarer CTCCs which can lead to the development of a secondary tumor. (b) CTCCs are composed of a heterogeneous mixture of CTCs and other cells commonly found in the bloodstream. This figure was created by <a href="https://doi.org/10.1016/j.jsamd.2019.01.006"><i> Rostami et al.</i> (2019)</a> and adapted for use here<sup>2</sup>.
												</figcaption>
											</figure>
											<br>
											<p style="color:black"> Cancer is a rare occurance under which some cells within the body grow uncontrollably into a clump of cells (tumor) before spreading to other parts of the body, forming a secondary tumor in a process known as metastasis<sup>1</sup>. 
												During the normal cell cycle, old or damaged cells die and are replaced by healthy, new cells. However, this process can sometimes fail, leading to these cells continuing to grow past normal restrictors of growth becoming cancerous<sup>1</sup>. To learn more click below to visit the National Cancer Insititue website.
											</p>
											<footer>
												<ul class="actions">
													<li><a href="https://www.cancer.gov/about-cancer/understanding/what-is-cancer" class="button1" style="color:black">Learn More</a></li>
												</ul>
											</footer>
										</section>
										<hr />
										<section>
											<h3 style="color:black">What is Metastasis and why should we care?</h3>
											<figure>
												<a href="https://seer.cancer.gov" class="image fit"><img src="images/SEERData.png" alt="Cancer statistics from SEER database" /></a>
												<figcaption style="color:black">
													Figure 3: Five-year survival rates for the three most common types of cancer in the USA as they grow from a local, to a regional, to a distant (metastatic) state. Values acquired from the National Cancer Institute Surveillance, Epidemiology, and End Results  <a href="https://seer.cancer.gov">(SEER)</a> Program<sup>3</sup>.
												</figcaption>
											</figure>
											<br>
											<p style="color:black"> During tumor growth, single circulating tumor cells (CTCs) and aggregates of circulating tumor cells called circulating tumor cell clusters (CTCCs) will be shed into the bloodstream (Figure 1)<sup>2</sup>. 
												These CTCs and CTCCs can escape into distant organs, forming a metastatic tumor. As the healthy cells compete with metastatic tumor cells for nutrients, the function of essential organs and systems can be impacted, leading to death. 
												Examining the five-year survival rates for patients with the three most common types of cancers in the US, metastatic growth signifcantly reduces a patients long-term survival (Figure 3)<sup>3</sup>.
												To learn more about metastasis click below.
											</p>
											<footer>
												<ul class="actions">
													<li><a href="metastasis.html" class="button1">Learn More </a></li>
												</ul>
											</footer>
										</section>
									</section>

							</div>
							<div class="col-8 col-12-medium imp-medium">

								<!-- Content -->
									<section id="content">
										<h3 style="color:black">What is Back-scatter Flow Cytometry?</h3>
										<figure>
											<a href="https://www.nature.com/articles/s41598-022-14003-5" class="image fit">
												<img src="images/FlowSystem.png.webp" alt="Summary of experimental system for CTCC detection." />
											</a>
											<figcaption style="color:black">
												Figure 2: (a) A microfluidic channel with whole blood flowing through it. (b) Schematic of the back-scatter flow cytometer (BSFC). D:dichroic, L:lens, M:mirror, BP:bandpass filter, BS:beam splitter, PMT:photomultiplier tube, Pol:polarizer, CAM:CCD camera, ND:neutral density filter, Cyl Lens:cylindrical lens. 
												(c) Schematic of experimental design. Blood is collected from mice and spiked with CTCCs before being flowed through a 30x30 &mu;<sup>2</sup> channel. Figure is reproduced from <a href="https://www.nature.com/articles/s41598-022-14003-5"> <i>Vora et al.</i> (2022)</a><sup>4</sup>.
										</figure>
										<br>
										<p style="color:black">
											Flow Cytometry ...
										</p>
										<footer>
											<ul class="actions">
												<li><a href="BSFC.html" class="button1">Learn More </a></li>
											</ul>
										</footer>
										<h3 style="color:black">Application of Machine Learning to BSFC Data</h3>
										<p style="color:black"> What is ML?
										</p>
										<h3 style="color:black">References</h3>
										<ol>
											<li style="color:black">What Is Cancer?. National Cancer Institute. <a href="https://www.cancer.gov/about-cancer/understanding/what-is-cancer">https://www.cancer.gov/about-cancer/understanding/what-is-cancer</a>. Accessed 12 November 2022.</li>
											<li style="color:black">Rostami, P. et al. Novel approaches in cancer management with circulating tumor cell clusters. J. Sci. Adv. Mater. Devices 4, 1–18 (2019). <a href="https://doi.org/10.1016/j.jsamd.2019.01.006">https://doi.org/10.1016/j.jsamd.2019.01.006</a></li>
											<li style="color:black">Howlader, N. et al. SEER Cancer Statistics Review, 1975–2017. Bethesda, MD. <a href="https://seer.cancer.gov/csr/1975_2017/">https://seer.cancer.gov/csr/1975_2017/</a>. Accessed 15 May 2021.</li>
											<li style="color:black">Vora, N. et al. Label-free flow cytometry of rare circulating tumor cell clusters in whole blood. Sci Rep 12, 10721 (2022). <a href="https://doi.org/10.1038/s41598-022-14003-5">https://doi.org/10.1038/s41598-022-14003-5</a></li>
										</ol>
									</section>

							</div>
						</div>
					</div>
				</div>
                    
			<!-- Footer -->
				<footer id="footer">
					<ul class="icons">
						<li><a href="https://www.linkedin.com/in/nilayvora/" class="icon brands alt fa-linkedin-in"><span class="label">LinkedIn</span></a></li>
						<li><a href="https://github.com/nilayvphd" class="icon brands alt fa-github"><span class="label">GitHub</span></a></li>
						<li><a href="https://gitlab.tufts.edu/nvora01" class="icon brands alt fa-gitlab"><span class="label">GitLab</span></a></li>
						<li><a href="https://scholar.google.com/citations?user=WOHFGOQAAAAJ&hl=en&oi=ao" class="icon brands alt fa-google"><span class="label">Google Scholar</span></a></li>
						<li><a href="mailto:nilay.vora@tufts.edu" class="icon solid alt fa-envelope"><span class="label">Email</span></a></li>
					</ul>
					<ul class="copyright">
						<li>&copy; Nilay Vora. All rights reserved.</li><li>Design: <a href="http://html5up.net">HTML5 UP</a></li>
					</ul>
				</footer>
        </div>

		<!-- Scripts -->
		<script src="assets/js/jquery.min.js"></script>
		<script src="assets/js/jquery.scrolly.min.js"></script>
		<script src="assets/js/jquery.dropotron.min.js"></script>
		<script src="assets/js/jquery.scrollex.min.js"></script>
		<script src="assets/js/browser.min.js"></script>
		<script src="assets/js/breakpoints.min.js"></script>
		<script src="assets/js/util.js"></script>
		<script src="assets/js/main.js"></script>
    </body>
</html>